European Journal of Medicinal Chemistry p. 3253 - 3258 (2009)
Update date:2022-08-03
Topics:
Fassihi, Afshin
Azadpour, Zahra
Delbari, Neda
Saghaie, Lotfollah
Memarian, Hamid R.
Sabet, Razieh
Alborzi, Abdolvahab
Miri, Ramin
Pourabbas, Bahman
Mardaneh, Jalal
Mousavi, Pegah
Moeinifard, Behzad
Sadeghi-aliabadi, Hojjat
A series of 4-substituted imidazolyl-2,6-dimethyl-N3,N5-bisaryl-1,4-dihydropyridine-3,5-dicarboxamides were prepared. They were screened as antitubercular agents against Mycobacterium tuberculosis H37Rv. Minimum inhibitory
View MoreChengdu CSH Pharmaceutical Co.,ltd
Contact:+86-(28)-85321971
Address:Block B,New Hope Int. Tian Fu New District, Chengdu, Sichuan, China
Contact:(86) 731 88718666
Address:Room 1222, Unit 4, Building B, Shangcheng, No.47, Kaiyuan East Road.
Beijing Zhongshuo Pharmaceutical T & D Co.,Ltd
Contact:0086-10-64430626
Address:ea No 16, HEPINGLI,DONGCHENG DISTRICT,BEIJING,P.R.CHINA.
Contact:+86-577-65618087-605
Address:Room 402, Unit 4 Xinhu Bldg. Waitan Ruian City, Zhejiang China.
Nantong Auxin Electronic Technology Co., LTD
Contact:86-513-88760026
Address:NO.5-1, Aoxin Road, Haian Hi-tech Development Zone, Jiangsu Province, China
Doi:10.1039/b900167k
(2009)Doi:10.1021/om900279p
(2009)Doi:10.1039/c39950002207
(1995)Doi:10.1016/S0040-4039(00)80269-5
(1988)Doi:10.1039/P19880001219
(1988)Doi:10.1016/j.tetlet.2009.04.089
(2009)